UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnostische Möglichkeiten und Grenzen der Thrombelastometrie/-graphie

Hämostaseologie, 2006, Vol.26 (S 01), p.S20-S29

2006

Volltextzugriff (PDF)

Fifth Åland Island conference on von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (S4), p.5-19

2018

Volltextzugriff (PDF)

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-09, Vol.22 (5), p.730-738

2016

Volltextzugriff (PDF)

von Willebrand's disease: a report from a meeting in the Åland islands

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-09, Vol.18 (s6), p.1-13

2012

Volltextzugriff (PDF)

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-03, Vol.22 (2), p.225-231

2016

Volltextzugriff (PDF)

Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.70-76

2018

Volltextzugriff (PDF)

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Haemophilia : the official journal of the World Federation of Hemophilia, 2010-09, Vol.16 (5), p.747-766

2010

Volltextzugriff (PDF)

Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction

Gene therapy, 2003-10, Vol.10 (22), p.1917-1925

2003

Volltextzugriff (PDF)

Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery

Thrombosis and haemostasis, 2011-06, Vol.105 (6), p.1072-1079

2011

Volltextzugriff (PDF)

Possibilities and limitations of thromboelastometry/thromboelastography

Hämostaseologie, 2006, Vol.26 (S 02), p.S21-S29

2006

Volltextzugriff (PDF)

Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery

British journal of anaesthesia : BJA, 2011-04, Vol.106 (4), p.494-500

2011

Volltextzugriff (PDF)

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature

Annals of hematology, 2009-01, Vol.88 (1), p.11-15

2009

Volltextzugriff (PDF)

Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1096-1103

2004

Volltextzugriff (PDF)

Canine haemophilia A caused by a mutation leading to a stop codon

Veterinary record, 2011-11, Vol.169 (19), p.496-496

2011

Volltextzugriff (PDF)

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-07, Vol.12 (4), p.363-371

2006

Volltextzugriff (PDF)

Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism

Blood, 2000-11, Vol.96 (10), p.3364-3368

2000

Volltextzugriff (PDF)

Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety

Haemophilia : the official journal of the World Federation of Hemophilia, 2005-11, Vol.11 (s1), p.18-23

VON DEPKA, M.

2005

Volltextzugriff (PDF)

Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates

Annals of the New York Academy of Sciences, 2005-06, Vol.1051 (1), p.498-505

2005

Volltextzugriff (PDF)

Major haemorrhage in neonates with haemophilia: Frequency and risk factors – European cohort study

Hämostaseologie, 2010, Vol.30 (S 01), p.S146-S147

2010

Volltextzugriff (PDF)

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-01, Vol.13 (1), p.38-45

2007

Volltextzugriff (PDF)

Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation

Journal of thrombosis and haemostasis, 2005-09, Vol.3 (9), p.1935-1944

2005

Volltextzugriff (PDF)

ITER study of patients with haemophilia A and factor VIII inhibitors

Hämostaseologie, 2010, Vol.30 (S 01), p.S46-S47

2010

Volltextzugriff (PDF)

Sequential combined bypassing therapy of bleeds unresponsive to a single bypassing agent: Safety and efficacy

Hämostaseologie, 2010, Vol.30 (S 01), p.S54-S55

2010

Volltextzugriff (PDF)

Management of acute haemarthrosis in haemophilia A: A European survey

Hämostaseologie, 2010, Vol.30 (S 01), p.S44-S45

2010

Volltextzugriff (PDF)

European curriculum for thrombosis and haemostasis

Haemophilia : the official journal of the World Federation of Hemophilia, 2009-01, Vol.15 (1), p.337-344

2009

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Englisch
(74)
Deutsch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(54)
Science & Technology
(54)
Humans
(53)
Hematology
(39)
Adult
(31)
Male
(31)
Female
(27)
Middle Aged
(23)
Aged
(19)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Adolescent
(16)
Child
(16)
Haemophilia
(10)
Hemophilia A - Drug Therapy
(10)
Recombinant Proteins - Therapeutic Use
(10)
Hematologic And Hematopoietic Diseases
(9)
Platelet Diseases And Coagulopathies
(9)
Factor Viii - Therapeutic Use
(8)
Medicin Och Hälsovetenskap
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnostische Möglichkeiten und Grenzen der Thrombelastometrie/-graphie

Fifth Åland Island conference on von Willebrand disease

Comparative pharmacokinetics of rVIII-SingleChain and octocog alfa (Advate®) in patients with severe haemophilia A

von Willebrand's disease: a report from a meeting in the Åland islands

Novel, human cell line-derived recombinant factor VIII (human-cl rhFVIII; Nuwiq®) in adults with severe haemophilia A: efficacy and safety

Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction

Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery

Possibilities and limitations of thromboelastometry/thromboelastography

Acquired type 2A von Willebrand syndrome caused by aortic valve disease corrects during valve surgery

Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature

Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey

Canine haemophilia A caused by a mutation leading to a stop codon

Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors

Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism

Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety

Inhibitor Development in Patients with Hemophilia A after Continuous Infusion of FVIII Concentrates

Major haemorrhage in neonates with haemophilia: Frequency and risk factors – European cohort study

Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors

Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation

ITER study of patients with haemophilia A and factor VIII inhibitors

Sequential combined bypassing therapy of bleeds unresponsive to a single bypassing agent: Safety and efficacy

Management of acute haemarthrosis in haemophilia A: A European survey

European curriculum for thrombosis and haemostasis

Suchergebnisse filtern